Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Thorsten R Doeppner, Dirk M HermannDepartment of Neurology, University of Duisburg-Essen Medical School, Essen, North Rhine-Westphalia, GermanyAbstract: Stroke is a major cause of death and long-term disability in industrialized countries, and the only causal therapy for stroke comprises recombinant...
Guardado en:
Autores principales: | Thorsten R Doeppner, Dirk M Hermann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ba7767083c04c44beeb5d5766cfa71b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-β/Smad2/3 pathway
por: Lin Zhang, et al.
Publicado: (2021) -
Mesenchymal stem cell therapy for osteoarthritis: current perspectives
por: Wyles CC, et al.
Publicado: (2015) -
Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives
por: Zomer HD, et al.
Publicado: (2015) -
Progress in stem cell-derived technologies for hepatocellular carcinoma
por: Rajagopal N Aravalli
Publicado: (2010) -
Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes
por: Jones OY, et al.
Publicado: (2011)